| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $150.8M | — | -2.6% |
| Cost of Revenue | $44.7M | — | -9.7% |
| Gross Profit | $106.2M | — | +0.7% |
| R&D Expense | $56.8M | — | -11.5% |
| SG&A Expense | $66.4M | — | -26.0% |
| Operating Income | -$17.0M | — | +56.7% |
| Pre-tax Income | -$12.8M | — | +61.7% |
| Income Tax | $623K | — | -26.9% |
| Net Income | -$13.5M | — | +60.8% |
| EPS (Basic) | -$0.10 | — | +64.3% |
| EPS (Diluted) | -$0.10 | — | +64.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $39.0M | -17.0% | -25.7% |
| Inventory | $53.5M | -5.1% | -28.4% |
| Current Assets | $669.7M | -2.2% | +15.5% |
| Total Assets | $1.02B | -2.5% | +12.4% |
| Current Liabilities | $113.6M | -26.0% | +5.3% |
| Total Liabilities | $201.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $26.1M | — | -24.0% |
| Capital Expenditures | $1.6M | — | -15.6% |
| Investing Cash Flow | -$1.3M | — | +30.7% |
| Financing Cash Flow | -$8.4M | — | -2094.5% |
| Free Cash Flow | $24.5M | — | -24.4% |
| +2.5% |
| Stockholders' Equity | $814.3M | +2.3% | +15.2% |